Analyst Update: Bio Blast Pharma, Centene, Goldcorp

Analysts adjusted their ratings on Bio Blast Pharma Ltd (NASDAQ:ORPN), Centene Corp (NYSE:CNC), and Goldcorp Inc. (USA) (NYSE:GG)

Jun 15, 2015 at 12:23 PM
facebook X logo linkedin


Analysts are weighing in today on biopharmaceutical firm Bio Blast Pharma Ltd (NASDAQ:ORPN), healthcare concern Centene Corp (NYSE:CNC), and gold producer Goldcorp Inc. (USA) (NYSE:GG). Here's a quick roundup of today's brokerage notes on ORPN, CNC, and GG.

  • Drugmakers are in the bullish crosshairs of brokerage firms today. For ORPN, this meant a price-target hike to $25 from $18 at Roth Capital, which expressed confidence the company's Phase III trial of its experimental muscular dystrophy drug -- which began today -- will wrap up sooner rather than later. The new price target, which resides in never-before-seen territory, has shares of ORPN up 27% at $7.31 -- and back in the black on a year-to-date basis. Widening the scope reveals today's optimistic outlook just echoes the withstanding sentiment. Roughly 0.1% of Bio Blast Pharma Ltd's float is sold short, and both analysts covering the shares maintain a "strong buy" recommendation.

  • CNC has received a number of bullish brokerage notes since the firm boosted its full-year forecast last Thursday morning. In fact, over the weekend, no fewer than six analysts upwardly revised their price targets. Included in the bunch was Barclays, which raised its target price to $88 from $84, as well as Cantor and Leerink, which both boosted their respective price targets to $85. Against this backdrop, CNC is up 3.7% today at $78.18, and fresh off an all-time peak of $78.27. Additional upbeat analyst attention could have the shares adding to their 50% year-to-date gain. More than half of those covering Centene Corp maintain a lukewarm "hold" recommendation, while the average 12-month price target of $78.20 is in line with current trading levels.

  • RBC cut its outlook on GG to "sector perform" from "outperform" and its price target to $21 from $24 -- sending the shares to a new six-year low of $16.59 out of the gate. At last check, the stock was down 0.9% at $16.70, bringing its 2015 deficit to 9.8%. Option traders have been rolling the dice on a rebound, though, by buying to open calls over puts at an accelerated clip in recent weeks. At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), Goldcorp Inc.'s 10-day call/put volume ratio of 9.05 sits just 7 percentage points from an annual high.
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI